Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DX25FVHMR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $61,126
Award facts
- Contract value 100% obligated
- $61,126.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $61,126.46 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on July 31, 2025, with an ultimate completion date of August 1, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
Dupixent (dupilumab) is a specialty biologic medication commonly prescribed for moderate-to-severe eczema, asthma, and other allergic conditions. The delivery order fulfills federal medical supply requirements for military healthcare programs and other government healthcare systems served under the DLA Troop Support Medical contract vehicle. AmerisourceBergen's extensive federal contract portfolio demonstrates the company's capability to meet competitive procurement requirements across a diverse range of pharmaceutical products and medical supplies. The company continues to play a significant role in the Defense Logistics Agency's pharmaceutical procurement strategy, with DLA Troop Support planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards across different contractors.
Quick answers
Who was awarded contract SPE2DX25FVHMR?
SPE2DX25FVHMR was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 31, 2025.
How much is contract SPE2DX25FVHMR worth?
The government has obligated $61,126 on SPE2DX25FVHMR.
Is contract SPE2DX25FVHMR an order under another contract?
Yes. SPE2DX25FVHMR is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVHMR competed?
The extent of competition for SPE2DX25FVHMR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award